Related Experiment Videos
Nickel-induced alterations in human renal epithelial cells
A Haugen1, L Maehle, S Mollerup
1Department of Toxicology, National Institute of Occupational Health, Oslo, Norway.
Environmental Health Perspectives
|September 1, 1994
Summary
Nickel (Ni2+) exposure immortalized normal human kidney epithelial (NHKE) cells by inducing p53 gene mutations. This, combined with v-Ha-ras, led to full tumorigenicity, highlighting nickel
Area of Science:
- Oncology
- Cell Biology
- Environmental Toxicology
Background:
- Cellular malignancy involves accumulating genetic damage in regulatory genes.
- Immortalization, or escaping senescence, is a critical early step in cancer development.
- Nickel compounds are known environmental carcinogens.
Purpose of the Study:
- To investigate the role of nickel (Ni2+) in the immortalization and malignant transformation of normal human kidney epithelial (NHKE) cells.
- To identify specific genetic alterations associated with nickel-induced cellular changes.
- To explore alterations in growth factor signaling during malignant progression.
Main Methods:
- In vitro culture of NHKE cells with Ni2+ exposure.
- Co-treatment with v-Ha-ras oncogene to assess tumorigenicity.
- DNA sequencing to analyze mutations in key genes, specifically p53.
- Analysis of cellular responses and receptor expression for epidermal growth factor (EGF) and transforming growth factor-beta (TGF-β).
Main Results:
- Ni2+ treatment successfully immortalized NHKE cells (designated IHKE cells).
- Combined Ni2+ and v-Ha-ras treatment induced full tumorigenicity in athymic nude mice.
- Sequence analysis revealed a point mutation (T-->C transition at codon 238) in the p53 gene of IHKE cells.
- Significant changes in cellular responses and receptor expression for EGF and TGF-β were observed during malignant progression.
Conclusions:
- Nickel-induced p53 gene mutation is implicated in the immortalization of NHKE cells.
- The study demonstrates a pathway for nickel-induced malignant transformation involving p53 mutation and oncogene cooperation.
- Alterations in EGF and TGF-β signaling pathways are associated with in vitro malignant progression.